BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7506115)

  • 1. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
    Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of malignant melanoma at the stage of distant metastasis].
    Garbe C; Eigentler TK
    Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
    Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cerebral metastases from malignant melanoma: results of a combined, simultaneous treatment with fotemustine and irradiation.
    Ulrich J; Gademann G; Gollnick H
    J Neurooncol; 1999 Jun; 43(2):173-8. PubMed ID: 10533730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
    Kjønniksen I; Breistøl K; Fodstad O
    Cancer Res; 1992 Mar; 52(5):1347-51. PubMed ID: 1737396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of melanoma].
    Dréno B; Wallon-Dumont G
    Presse Med; 2003 Jan; 32(1):39-43. PubMed ID: 12610396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated limb perfusion with fotemustine after chemosensitization with dacarbazine in melanoma.
    Pontes L; Lopes M; Ribeiro M; Santos JG; Azevedo MC
    Melanoma Res; 1997 Oct; 7(5):417-9. PubMed ID: 9429225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
    Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A
    Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod in the treatment of metastatic melanoma to skin.
    Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
    Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
    [No Abstract]   [Full Text] [Related]  

  • 13. Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
    Khayat D; Avril MF; Gerard B; Bertrand P; Bizzari JP; Cour V
    Melanoma Res; 1992 Sep; 2(3):147-51. PubMed ID: 1450667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study.
    Farolfi A; Ridolfi L; Guidoboni M; Milandri C; Calzolari F; Scarpi E; Amadori D; Ridolfi R
    J Chemother; 2011 Oct; 23(5):300-5. PubMed ID: 22005064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the chemotherapy of melanoma.
    Glover DJ
    Oncology (Williston Park); 1991 May; 5(5):95-8; discussion 101-2, 104. PubMed ID: 1715735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity testing in malignant melanoma.
    Ugurel S; Tilgen W; Reinhold U
    Recent Results Cancer Res; 2003; 161():81-92. PubMed ID: 12528801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fotemustine--an advance in the treatment of metastatic malignant melanoma.
    Merimsky O; Inbar M; Gerard B; Chaitchik S
    Melanoma Res; 1992 Dec; 2(5-6):401-6. PubMed ID: 1292787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete remission seven years after treatment for metastatic malignant melanoma.
    Petit T; Borel C; Rixe O; Avril MF; Monnier A; Giroux B; Weil M; Khayat D
    Cancer; 1996 Mar; 77(5):900-2. PubMed ID: 8608481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cells.
    Reinhold U; Ugurel S; Tilgen W; Kadiata MM; Olivares E; Nadi AB; Malaisse WJ
    Oncol Rep; 2000; 7(5):1093-7. PubMed ID: 10948345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fotemustine: muphoran].
    Avril MF
    Ann Dermatol Venereol; 2007 Dec; 134(12):997-1000. PubMed ID: 18166925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.